{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:03:18Z","timestamp":1773280998598,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Allergy Immunology"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>House dust mite (<jats:styled-content style=\"fixed-case\">HDM<\/jats:styled-content>) respiratory allergy is a common and burdensome disease in children and adolescents. There are few <jats:styled-content style=\"fixed-case\">HDM<\/jats:styled-content> allergy immunotherapy trials in children with perennial allergic rhinitis. This post hoc analysis used pooled data to evaluate efficacy and safety of the <jats:styled-content style=\"fixed-case\">SQ HDM<\/jats:styled-content> sublingual immunotherapy (<jats:styled-content style=\"fixed-case\">SLIT<\/jats:styled-content>) tablet in adolescents (12\u201017\u00a0years).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In two double\u2010blind, placebo\u2010controlled trials conducted in North America and Japan, respectively, subjects aged 12+ years with <jats:styled-content style=\"fixed-case\">HDM<\/jats:styled-content> allergic rhinitis were randomized to up to 1\u00a0year of treatment. The primary end\u2010point in both trials was the average total combined rhinitis score (<jats:styled-content style=\"fixed-case\">TCRS<\/jats:styled-content>) during the last 8\u00a0weeks of treatment in the active group compared with placebo. Data from subjects aged 12\u201017\u00a0years were pooled (N=395).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the pooled adolescent subpopulation, average <jats:styled-content style=\"fixed-case\">TCRS<\/jats:styled-content> improved 22% with 12 <jats:styled-content style=\"fixed-case\">SQ HDM<\/jats:styled-content> vs placebo (absolute treatment difference of 1.04; <jats:italic>P<\/jats:italic>&lt;.01). Rhinitis daily symptom score (<jats:styled-content style=\"fixed-case\">DSS<\/jats:styled-content>), conjunctivitis <jats:styled-content style=\"fixed-case\">DSS<\/jats:styled-content> and rhinitis daily medication score (<jats:styled-content style=\"fixed-case\">DMS<\/jats:styled-content>) were also significantly improved vs placebo in the pooled adolescent subpopulation (all <jats:italic>P<\/jats:italic>&lt;.05). There were no new safety signals for adolescents. The frequency of adverse events was similar in adolescents and adults with the majority being mild application site\u2010related events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Treatment with 12 <jats:styled-content style=\"fixed-case\">SQ HDM<\/jats:styled-content> appears to be effective and well tolerated in adolescents with <jats:styled-content style=\"fixed-case\">HDM<\/jats:styled-content> allergic rhinitis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/pai.12747","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T07:12:38Z","timestamp":1498720358000},"page":"661-667","source":"Crossref","is-referenced-by-count":23,"title":["Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents"],"prefix":"10.1111","volume":"28","author":[{"given":"Tomokazu","family":"Matsuoka","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Head &amp; Neck Surgery Faculty of Medicine Graduate Faculty of Interdisciplinary Research University of Yamanashi  Yamanashi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Bernstein Clinical Research Center and Division of Allergy and Immunology University of Cincinnati  Cincinnati OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Masuyama","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head &amp; Neck Surgery Faculty of Medicine Graduate Faculty of Interdisciplinary Research University of Yamanashi  Yamanashi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Nolte","sequence":"additional","affiliation":[{"name":"Research and Development ALK  H\u00f8rsholm Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Okamiya","sequence":"additional","affiliation":[{"name":"Clinical Development Department Torii Pharmaceutical Co. Ltd.  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorthe","family":"Seitzberg","sequence":"additional","affiliation":[{"name":"Research and Development ALK  H\u00f8rsholm Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold S.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Division of Allergy\/Immunology Department of Medicine National Jewish Health  Denver CO USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00013904"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.05.013"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.08.014"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.09.004"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.06.044"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.043"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.06.036"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.11.015"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.019"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.12.1911"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3964"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2015.10.024"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000444016"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.03.039"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01312.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.04.061"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.12.155"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528110-00006"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1998.tb04930.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01586.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3282f1d67e"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306300"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2015.09.018"},{"key":"e_1_2_7_25_1","unstructured":"ICH.ICH Harmonised Tripartite Guideline Topic E2A. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting 1994."}],"container-title":["Pediatric Allergy and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpai.12747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pai.12747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T14:53:11Z","timestamp":1695567191000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pai.12747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1111\/pai.12747"],"URL":"https:\/\/doi.org\/10.1111\/pai.12747","archive":["Portico"],"relation":{},"ISSN":["0905-6157","1399-3038"],"issn-type":[{"value":"0905-6157","type":"print"},{"value":"1399-3038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]}}}